Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Selcia Limited
Selcia Limited
Activities:
Research & Development
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Media
Selcia joins Eurofins Group
Selcia, specialist provider of custom radiolabelling and integrated drug discovery services, announced it has been acquired by Eurofins Scientific, a global specialist in analytical testing and pharma discovery services
Research & Development
Selcia publishes strategy for structural simplification of natural products
The paper outlines a technique to generate synthetically tractable cyclophilin inhibitors for the treatment of hepatitis C
Ingredients
Selcia opens new dedicated 14C GMP API facility
To help the firm meet increasing demand for 14C radiolabelled compounds
Research & Development
Selcia and Cantab announce drug discovery collaboration
To develop improved antibiotics for multi-drug resistant Gram-negative bacterial infections
Ingredients
Selcia granted patent for drug discovery platform
The patent covers technology underpinning the UK-based company’s CEfrag drug screening service
Research & Development
Selcia exploits in-house IP with demerger
Forms Mitopharm and Selcia Pharma to protect IP while attracting external investment
Research & Development
Convergence Pharmaceuticals and Selcia in r&d collaboration
Aim is to identify and develop high quality candidate molecules for the treatment of chronic pain
Subscribe now